Psychiatry and Neurology, Neurology · Baton Rouge, LA
NPI
1245229459
Since 2005
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
5427 Didesse Drive
Baton Rouge, LA, 70808
Phone (225) 215-2193
Groups this clinician bills Medicare through
Medicare paid, 2024
$138K
11,376 services
Medicare patients, 2024
345
Average age 69
Drug cost, 2024
$7.4M
7,673 prescriptions
Company payments, 2025
$60K
From 41 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kevin J Callerame was code J0585 (injection, onabotulinumtoxina, 1 unit), 9,300 times for 12 patients. In total Kevin J Callerame billed 11,376 services in 47 codes, and Medicare paid $138K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-01-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 9,300 | 12 | $4.98 | $46K |
| 99213 Office E&M - Established | Office | 244 | 165 | $60.88 | $15K |
| 99214 Office E&M - Established | Office | 121 | 99 | $83.20 | $10K |
| 99205 Office E&M - New | Office | 84 | 84 | $143.60 | $12K |
| 95886 Electrical Nerve Conductivity | Office | 58 | 31 | $67.78 | $3,931 |
| 95816 Neurologic | Facility | 26 | 26 | $37.57 | $977 |
| 95816 Neurologic | Office | 20 | 20 | $248.37 | $4,967 |
| 95911 Electrical Nerve Conductivity | Office | 14 | 14 | $153.24 | $2,145 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 13 | 13 | $11.30 | $147 |
By year: 2022 $123K for 9,137 services; 2023 $135K for 10,424 services; 2024 $138K for 11,376 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kevin J Callerame prescribed most often to Medicare patients was Memantine Hcl, with 732 prescriptions and refills. In total Kevin J Callerame wrote 7,673 Medicare prescriptions that cost $7.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Memantine Hcl Generic | 732 | 1,206 | 176 | $14K |
| Gabapentin Generic | 483 | 700 | 113 | $7,226 |
| Levetiracetam Generic | 437 | 768 | 87 | $15K |
| Donepezil Hcl Generic | 266 | 469 | 70 | $2,268 |
| Baclofen Generic | 252 | 350 | 54 | $2,992 |
| Lamotrigine Generic | 207 | 328 | 35 | $3,823 |
| Topiramate Generic | 197 | 404 | 60 | $1,687 |
| Ubrelvy Ubrogepant | 176 | 177 | 52 | $244K |
| Primidone Generic | 172 | 278 | 32 | $4,890 |
| Qulipta Atogepant | 141 | 149 | 26 | $165K |
| Carbidopa-Levodopa Carbidopa/Levodopa | 139 | 254 | 34 | $3,298 |
| Quetiapine Fumarate Generic | 139 | 202 | 37 | $1,184 |
| Clonazepam Generic | 136 | 138 | 25 | $879 |
| Oxcarbazepine Generic | 119 | 210 | 27 | $11K |
| Radicava Ors Edaravone | 116 | 116 | 23 | $1.7M |
Brand drugs: 1,418 claims; generic drugs: 6,144 claims; opioid claims: 25.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kevin J Callerame $60K ($60K in general payments such as food, travel and fees) from 41 companies. The largest payer was Abbvie Inc. with $55K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.